Sukhatme Mayukh — SEC insider filings
SEC reporting owner CIK 1750050. 22 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2022-04-22 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 8 filings — 4,995,961 shares, $124,746,623 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 70.
- Largest priced transaction: sale of 1,018,995 shares @ $21.71 ($22,122,381) in Roivant Sciences Ltd., filed 2025-12-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | President & CIO, Director | 22 | — | 17 legs · 4,995,961 sh · $124,746,623 | 70 |
Insider filings — Sukhatme Mayukh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Roivant Sciences Ltd. (ROIV) | Other (J): 26,152 @ $40.43 · Other (J): 32,882 @ $41.13 · Other (J): 32,672 @ $41.63 · Other (J): 20,533 @ $42.01 · Other (J): 44,723 @ $40.36 · Other (J): 8,482 @ $41.13 · +1 more | EDGAR |
| 2026-10-20 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 19,976 @ $33.53 | EDGAR |
| 2026-10-02 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 46,879 @ $36.57 | EDGAR |
| 2026-08-21 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 172,899 @ $3.85 · Sale (S): 172,899 @ $37.17 · Option exercise (M): 17,519 @ $3.85 · Sale (S): 17,519 @ $37.30 · Option exercise (M): 144,756 @ $3.85 · Sale (S): 144,756 @ $36.48 · +3 more | EDGAR |
| 2026-08-18 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 243,177 @ $3.85 · Sale (S): 243,177 @ $36.23 · Option exercise (M): 284,707 @ $3.85 · Sale (S): 284,707 @ $36.25 · Option exercise (M): 105,141 @ $3.85 · Sale (S): 105,141 @ $36.59 · +5 more | EDGAR |
| 2026-07-02 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 46,878 @ $35.39 | EDGAR |
| 2026-06-29 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 500,000 @ $3.85 · Sale (S): 500,000 @ $34.13 · Option exercise (M): 500,000 @ $3.85 · Sale (S): 500,000 @ $34.08 · Option exercise (M): 500,000 (derivative) @ $0 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 58,391 · Tax withholding (F): 29,809 @ $26.41 · Tax withholding (F): 187,512 @ $27.70 · Option exercise (M): 1,306,889 (derivative) @ $11.50 | EDGAR |
| 2026-02-11 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 651,558 @ $12.68 · Sale (S): 339,441 @ $26.47 · Other (J): 312,117 @ $26.47 · Option exercise (M): 651,558 (derivative) @ $0 | EDGAR |
| 2025-12-31 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 748,358 @ $12.68 · Sale (S): 311,873 @ $21.74 · Other (J): 436,485 @ $21.74 · Option exercise (M): 2,449,877 @ $12.68 · Sale (S): 1,018,995 @ $21.71 · Other (J): 1,430,882 @ $21.71 · +2 more | EDGAR |
| 2025-12-19 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 59,513 @ $12.68 · Sale (S): 26,831 @ $23.09 · Other (J): 32,682 @ $23.09 · Option exercise (M): 59,513 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 10,796 @ $3.85 · Sale (S): 10,796 @ $12 · Option exercise (M): 185,946 @ $3.85 · Sale (S): 185,946 @ $12 · Option exercise (M): 689,495 @ $3.85 · Sale (S): 689,495 @ $12.01 · +3 more | EDGAR |
| 2024-12-20 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 412,584 @ $3.85 · Sale (S): 412,584 @ $12.05 · Option exercise (M): 412,584 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | Roivant Sciences Ltd. (ROIV) | Other (J): 3,651,985 @ $12.21 | EDGAR |
| 2024-07-30 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 1,836,547 @ $0 · Grant/award (A): 17,000,000 @ $0 | EDGAR |
| 2024-04-02 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 729,081 · Tax withholding (F): 366,211 @ $10.54 · Option exercise (M): 1,856,163 (derivative) @ $6.40 | EDGAR |
| 2023-12-29 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 71,365 · Option exercise (M): 159,100 (derivative) @ $6.40 · Option exercise (M): 28,411 (derivative) @ $11.50 | EDGAR |
| 2023-09-29 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 27,790 · Option exercise (M): 53,033 (derivative) @ $6.40 · Option exercise (M): 28,411 (derivative) @ $11.50 | EDGAR |
| 2023-08-29 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 22,565 · Option exercise (M): 53,033 (derivative) @ $6.40 | EDGAR |
| 2023-07-31 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 43,212 · Option exercise (M): 106,067 (derivative) @ $6.40 | EDGAR |
| 2023-05-31 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 99,458 · Option exercise (M): 318,199 (derivative) @ $6.40 | EDGAR |
| 2022-04-22 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 16,523,184 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1750050 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs